Gastrointestinal symptoms such as nausea or mild stomach discomfort were also reported during early treatment or following dose escalation
However, the impact on future fertility remains uncertain, and there is a small chance of fibroid recurrence
Li N, Zhao L, Geng X, Liu J, Zhang X, Hu Y, Qi J, Chen H, et al
Increasing NAD synthesis in muscle via nicotinamide phosphoribosyltransferase is not [PMID: 25411251] Laboratory literature summary: Increasing NAD synthesis in muscle via nicotinamide phosphoribosyltransferase is not sufficient to promote oxidative metabolism
Foundayo (Orforglipron) Foundayo is a newly approved GLP-1 medication available as a daily pill